Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study

Author:

Gambacorti-Passerini Carlo1,Orlov Sergey2,Zhang Li3,Braiteh Fadi4,Huang Huiqiang5,Esaki Taito6,Horibe Keizo7,Ahn Jin-Seok8,Beck Joseph T.9,Edenfield William Jeffrey10,Shi Yuankai11ORCID,Taylor Matthew12,Tamura Kenji13ORCID,Van Tine Brian A.14,Wu Shang-Ju15,Paolini Jolanda16,Selaru Paulina17,Kim Tae Min18

Affiliation:

1. University of Milano Bicocca, San Gerardo Hospital; Monza Italy

2. St Petersburg Medical University; St Petersburg Russia

3. State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center; Guangdong China

4. Comprehensive Cancer Centers of Nevada; Las Vegas Nevada

5. Department of Medical Oncology; Sun-Yat Sen University Cancer Center; Guangdong China

6. National Kyushu Cancer Center; Fukuoka Japan

7. National Hospital Organization Nagoya Medical Center; Nagoya Japan

8. Samsung Medical Center, Sungkyunkwan University School of Medicine; Seoul South Korea

9. Highlands Oncology Group; Fayetteville Arkansas

10. Cancer Institute of Greenville Health System; Greenville South Carolina

11. Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs; National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; Beijing China

12. Oregon Health & Science University; Portland Oregon

13. National Cancer Center Hospital; Tokyo Japan

14. Washington University School of Medicine; St. Louis Missouri

15. National Taiwan University Hospital; Taipei Taiwan

16. Pfizer Oncology; Milan Italy

17. Pfizer Oncology; La Jolla California

18. Seoul National University Hospital; Seoul South Korea

Funder

Pfizer Inc.

Publisher

Wiley

Subject

Hematology

Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3